Congressional Trader
Live

MRNA congressional trades

4 matched disclosures

Track congressional trades for MRNA
Tracked disclosures
4
Lawmakers
3
Buy / sell
1 / 3
Avg post-trade move
N/A
Latest filing 2025-05-08

MRNA congressional trades snapshot

This page summarizes public STOCK Act disclosures involving MRNA. It is useful for seeing which lawmakers reported MRNA transactions, how many filings are visible, the buy/sell mix, and whether the newest public filing describes a recent or delayed trade.

Last updated

May 8, 2025

Data source

Public House and Senate STOCK Act disclosures normalized by Congressional Trader.

Key caveat

Filing date can trail transaction date. This page is for research and monitoring, not investment advice.

What the MRNA congressional trade page shows

Congressional Trader tracks 4 public STOCK Act disclosures for MRNAacross 3 lawmakers. This page separates purchases from sales, shows filing delays, and links each disclosure back to the individual politician profile when available.

The most recent MRNA filing shown here was filed on May 8, 2025 by Robert P. Bresnahan as a sale. Related lawmakers include Robert P. Bresnahan, Josh Gottheimer, Julie Johnson.

Pro performance summary

Unlock 30/90-day post-trade summaries, committee overlap, and CSV-oriented research views for high-intent ticker research.

Compare Pro plans
No committee data
Filed May 8, 2025
Delay 30 days
View filing
MRNANotable
Moderna, Inc. - Common Stock
Sale
$1K - $15K
Expert AnalysisPro
/ 100 Political Alpha

Upgrade to see committee overlap, performance context, and full expert analysis.

Buy price
Return since trade
Follow $10K gain
Expert analysis is Pro-only
Upgrade
No committee data
Filed Mar 27, 2025
Delay 30 days
View filing
MRNANotable
Moderna, Inc. - Common Stock
Purchase
$1K - $15K
Expert AnalysisPro
/ 100 Political Alpha

Upgrade to see committee overlap, performance context, and full expert analysis.

Buy price
Return since trade
Follow $10K gain
Expert analysis is Pro-only
Upgrade
Julie JohnsonD-TXHouse
No committee data
Filed Feb 12, 2025
Delay 28 days
View filing
Moderna, Inc. - Common Stock
Sale
$1K - $15K
Expert AnalysisPro
/ 100 Political Alpha

Upgrade to see committee overlap, performance context, and full expert analysis.

Buy price
Return since trade
Follow $10K gain
Expert analysis is Pro-only
Upgrade
No committee data
Filed Mar 7, 2024
Delay 35 days
View filing
MRNANotable
Moderna, Inc. - Common Stock
Sale
$1K - $15K
Expert AnalysisPro
/ 100 Political Alpha

Upgrade to see committee overlap, performance context, and full expert analysis.

Buy price
Return since trade
Follow $10K gain
Expert analysis is Pro-only
Upgrade

FAQ

Which lawmakers traded MRNA?

Recent MRNA disclosures include Robert P. Bresnahan, Josh Gottheimer, Julie Johnson.

What is the buy/sell mix for MRNA?

The visible sample currently shows 1 purchases and 3 sales or partial sales.

Should I trade based on MRNA disclosures?

No. This page summarizes public filings for research and monitoring. It is not investment advice.